Search Results

IPA Acquires the Carterra LSA ® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments.

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that it has entered into an agreement with LS Associates, a division of LifeSci Advisors, LLC, pursuant to which LSA will provide certain consulting services to the Company, including but not limited to, arranging for the provision of the Company’s Interim Chief Financial Officer.

Zealand Pharma A/S announces the receipt on 9 January 2024 of notification pursuant to Section 38 of the Danish Capital Markets Act from Avoro Capital Advisors LLC.

Edwards Lifesciences announced it has entered into a definitive agreement to sell its Critical Care product group to BD, in an all-cash transaction valued at $4.2 billion.

Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC.

Standard BioTools Inc. announced that it has purchased the LSAXT system from Carterra®, a leading provider of high-throughput large and small molecule screening and characterization solutions.

Maravai LifeSciences Holdings, Inc., a global provider of life science reagents and services to researchers and biotech innovators, reported financial results for the first quarter ended March 31, 2024, together with other business updates.